Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04336618 · ClinicalTrials.gov registry record
Multi-Parametric MRI Assessment of the Liver in the Dallas-FortWorth Metroplex Population
A clinical trial, sponsored by Perspectum.
- Completed
- Registry status
- 67
- Enrollment target
NCT04336618: Completed study, sponsored by Perspectum.
NCT04336618 is a clinical trial that has completed, run by Perspectum. The registered enrollment target is 67 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04336618 has completed, sponsored by Perspectum.
- COMPLETED
- Registry status
- 67 participants
- Enrollment target
Study Summary
To build a Registry of volunteers by inviting them to get a LiverMultiScan(LMS)and collecting their contact information to seek interest in participating in future studies.
Interventions
- DEVICE Liver MultiScan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2020-08-03 |
| Est. Completion | 2022-09-27 |
What the finished NCT04336618 record still lists
NCT04336618 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 67 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Liver MultiScan is the first listed.
NCT04336618 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04336618 about?
NCT04336618 is a clinical study titled "Multi-Parametric MRI Assessment of the Liver in the Dallas-FortWorth Metroplex Population". To build a Registry of volunteers by inviting them to get a LiverMultiScan(LMS)and collecting their contact information to seek interest in participating in future studies.
What is the current status of trial NCT04336618?
This trial is currently completed. The enrollment target is 67 participants. The study started on 2020-08-03. Estimated completion is 2022-09-27.
What interventions are being tested in trial NCT04336618?
The interventions under investigation include: Liver MultiScan (DEVICE).
Who is sponsoring clinical trial NCT04336618?
This trial is sponsored by Perspectum, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI